Erythropoietin in the brain: Can the promise to protect be fulfilled?

Trends in Pharmacological Sciences

Volumn 25, Issue 11, 2004, Pages 577-583

  Maiese, Kenneth ^a,b   Li, Faqi ^a   Chong, Zhao Zhong ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Inst Environ Hlth Sci Wayne S   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 2; PROTEIN BAD; PROTEIN BCL XL; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR;

ANGIOGENESIS; APOPTOSIS; BRAIN; BRAIN INJURY; BRAIN ISCHEMIA; CELL DAMAGE; CELL PROLIFERATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ENCEPHALITIS; ENZYME ACTIVITY; FEVER; HEART INFARCTION; HUMAN; HYPERTENSION; NEUROPATHIC PAIN; NEUROPROTECTION; NEUROTOXICITY; NEWBORN HYPOXIA; NONHUMAN; OXIDATIVE STRESS; PARESTHESIA; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RETINA ISCHEMIA; REVIEW; SIDE EFFECT; SPINAL CORD INJURY; SUBARACHNOID HEMORRHAGE; THROMBOSIS; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

APOPTOSIS; BRAIN; CYTOPROTECTION; ERYTHROPOIETIN; HUMANS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RECEPTORS, ERYTHROPOIETIN;

EID: 5644245234     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.09.006     Document Type: Review

References (75)

1. S.B. Krantz Erythropoietin Blood 77 1991 419 434
2. E. Uchida Effect of active oxygen radicals on protein and carbohydrate moieties of recombinant human erythropoietin Free Radic. Res. 27 1997 311 323
3. O.J. Nielsen Regulation of erythropoietin production in a human hepatoblastoma cell line Blood 70 1987 1904 1909
4. F.F. Wang Some chemical properties of human erythropoietin Endocrinology 116 1985 2286 2292
5. Z.Z. Chong Erythropoietin: Cytoprotection in vascular and neuronal cells Curr Drugs Targets-Cardiovasc Haematol Disord. 3 2003 141 154
6. S. Genc Erythropoietin as a novel neuroprotectant Restor Neurol Neurosci 22 2004 105 119
7. H.H. Marti Erythropoietin and the hypoxic brain J. Exp. Biol. 207 2004 3233 3242
8. Z.Z. Chong Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades J. Cereb. Blood Flow Metab. 22 2002 503 514
9. M. Bernaudin A potential role for erythropoietin in focal permanent cerebral ischemia in mice J. Cereb. Blood Flow Metab. 19 1999 643 651
10. M. Heidbreder Hypoxia rapidly activates HIF-3alpha mRNA expression FASEB J. 17 2003 1541 1543
11. N. Obara Suppression of erythropoietin gene expression by cadmium depends on inhibition of HIF-1, not stimulation of GATA-2 Arch. Toxicol. 77 2003 267 273
12. A. Nagai Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture J. Neuropathol. Exp. Neurol. 60 2001 386 392
13. L. Studer Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen J. Neurosci. 20 2000 7377 7383
14. T. Shingo Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells J. Neurosci. 21 2001 9733 9743
15. S.M. Lee EPO receptor-mediated ERK kinase and NF-kappaB activation in erythropoietin-promoted differentiation of astrocytes Biochem. Biophys. Res. Commun. 320 2004 1087 1095
16. J.Y. Lee Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors NeuroReport 14 2003 1401 1404
17. M. Sakanaka In vivo evidence that erythropoietin protects neurons from ischemic damage Proc. Natl. Acad. Sci. U. S. A. 95 1998 4635 4640
18. N.V. Olsen Central nervous system frontiers for the use of erythropoietin Clin. Infect. Dis. 37 Suppl. 4 2003 S323 S330
19. G. Grasso Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage Proc. Natl. Acad. Sci. U. S. A. 99 2002 5627 5631
20. E. Kaptanoglu Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings Neurosurg. Rev. 27 2004 113 120
21. C. Grimm HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration Nat. Med. 8 2002 718 724
22. Y. Sekiguchi Erythropoietin inhibits spinal neuronal apoptosis and pain following nerve root crush Spine 28 2003 2577 2584
23. W.M. Campana, and R.R. Myers Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury Eur. J. Neurosci. 18 2003 1497 1506
24. M. Sugawa Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation Neurosci. Res. 44 2002 391 403
25. M.L. Brines Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc. Natl. Acad. Sci. U. S. A. 97 2000 10526 10531
26. O.M. Martinez-Estrada Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability Eur. J. Neurosci. 18 2003 2538 2544
27. M. Buemi Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration Nephrol. Dial. Transplant. 15 2000 422 423
28. Z.Z. Chong Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases Circulation 106 2002 2973 2979
29. Z.Z. Chong Angiogenesis and plasticity: role of erythropoietin in vascular systems J. Hematother. Stem Cell Res. 11 2002 863 871
30. Z.Z. Chong Apaf-1, Bcl-xL, Cytochrome c, and Caspase-9 Form the Critical Elements for Cerebral Vascular Protection by Erythropoietin J. Cereb. Blood Flow Metab. 23 2003 320 330
31. D. Ribatti Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo Blood 93 1999 2627 2636
32. L. Wang Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats Stroke 35 2004 1732 1737
33. N. Battista Endocannabinoids and their involvement in the neurovascular system Curr. Neurovasc. Res. 1 2004 129 140
34. Z.Z. Chong Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system Antioxid. Redox Signal. 6 2004 277 287
35. O. Ekshyyan, and T.Y. Aw Apoptosis in acute and chronic neurological disorders Front. Biosci. 9 2004 1567 1576
36. M.P. Mattson Neuronal and glial calcium signaling in Alzheimer's disease Ca(2+) stores and capacitative Ca(2+) entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer's disease presenilin-1 mutation Cell Calcium 34 2003 385 397
37. K. Maiese, and Z.Z. Chong Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease Restor. Neurol. Neurosci. 22 2004 87 104
38. Z.Z. Chong Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8 J. Neurosci. Res. 71 2003 659 669
39. Z.Z. Chong Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways Br. J. Pharmacol. 138 2003 1107 1118
40. Z.Z. Chong Akt1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-x(L) and caspase 1, 3, and 9 Exp. Cell Res. 296 2004 196 207
41. E. Morishita Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death Neuroscience 76 1997 105 116
42. G. Calapai Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation Eur. J. Pharmacol. 401 2000 349 356
43. X.Q. Wang, and N.D. Vaziri Erythropoietin depresses nitric oxide synthase expression by human endothelial cells Hypertension 33 1999 894 899
44. M. Digicaylioglu Erythropoietin protects cerebrocortical neurons from HIV-1/gp120-induced damage NeuroReport 15 2004 761 763
45. J.Q. Kang Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity J. Neurosci. Res. 74 2003 37 51
46. A. Witting Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition J. Neurochem. 75 2000 1060 1070
47. E. Spandou Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia Neurosci. Lett. 366 2004 24 28
48. A. Kumral Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats Behav. Brain Res. 153 2004 77 86
49. C.J. Parsa Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts J. Biol. Chem. 279 2004 20655 20662
50. N. Casadevall Pure Red-Cell Aplasia and Antierythropoietin antibodies in patients treated with recombinant erythropoietin New Engl. J. Med. 346 2002 469 475
51. F. Verdier Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors J. Biol. Chem. 275 2000 18375 18381
52. M. Kawakami Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia J. Biol. Chem. 276 2001 39469 39475
53. H. Bao Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells) Blood 93 1999 3757 3773
54. M. Dzietko Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity Neurobiol. Dis. 15 2004 177 187
55. J.H. Weishaupt Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells Invest. Ophthalmol. Vis. Sci. 45 2004 1514 1522
56. Z.Z. Chong The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential J. Cereb. Blood Flow Metab. 24 2004 728 743
57. A. Brunet Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96 1999 857 868
58. D.L. Mahmud Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells Oncogene 21 2002 1556 1562
59. Z.Z. Chong, and K. Maiese Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system Histol. Histopathol. 19 2004 495 504
60. T.C. Somervaille Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax Blood 98 2001 1374 1381
61. M. Vairano Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro Eur. J. Neurosci. 16 2002 684 692
62. Y.G. Figueroa NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression Exp. Hematol. 30 2002 1419 1427
63. H. Matsushita Protective effect of erythropoietin in neonatal hypoxic ischemia in mice NeuroReport 14 2003 1757 1761
64. N.G. Bazan Hypoxia signaling to genes: significance in Alzheimer's disease Mol. Neurobiol. 26 2002 283 298
65. H. Zhou Akt regulates cell survival and apoptosis at a postmitochondrial level J. Cell Biol. 151 2000 483 494
66. J.Q. Kang Critical role for akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation Mol. Pharmacol. 64 2003 557 569
67. W. Jelkmann Erythropoietin: structure, control of production, and function Physiol. Rev. 72 1992 449 489
68. H. Ehrenreich Erythropoietin therapy for acute stroke is both safe and beneficial Mol. Med. 8 2002 495 505
69. H. Ehrenreich Erythropoietin: a candidate compound for neuroprotection in schizophrenia Mol. Psychiatry 9 2004 42 54
70. K. Miyashita Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients Hypertens. Res. 27 2004 79 84
71. D.H. Henry Epoetin alfa. Clinical evolution of a pleiotropic cytokine Arch. Intern. Med. 164 2004 262 276
72. C. Wiessner Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin J. Cereb. Blood Flow Metab. 21 2001 857 864
73. M. Leist Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 2004 239 242
74. W.M. Campana Identification of a neurotrophic sequence in erythropoietin Int. J. Mol. Med. 1 1998 235 241
75. J.M. Gil Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice BMC Neurosci. 5 2004 17